Choose Your language:
- Testimonials
-
great service thanks
- andrew
Read more »
Our billing is certified by:
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- Bristol-Myers Squibb to Present New Data on ORENCIA(R)â-¼ (abatacept) at the ... - MarketWatch (press release)
- Asian Scientist MagazineBristol-Myers Squibb to Present New Data on ORENCIA(R)â-¼ (abatacept) at the
- New Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in ... - MarketWatch (press release)
- New Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in
- Regeneron: - FierceBiotech
- Regeneron:FierceBiotechIts Phase IIb 'MOBILITY' trial showed that the drug, sarilumab, in combination with the standard RA treatment methotrexate, made a 'significant and clinically meaningful improvement' in RA patients' symptoms compared with those who in the study treated
- Infection Risk High in Juvenile Arthritis - MedPage Today
- MedPage TodayInfection Risk High in Juvenile ArthritisMedPage TodayNote that among children with JIA, the rate of infection was not increased with methotrexate or tumor necrosis factor inhibitor use
- When the Reasons Are Unreasonable: The Childhood Cancer Drug Shortage - Huffington Post
- When the Reasons Are Unreasonable: The Childhood Cancer Drug ShortageHuffington PostSome of you may recall when earlier this year a story hit the news about a nationwide shortage of the lifesaving childhood cancer drug, methotrexate
